New bat-borne virus related to Ebola discovered by Singapore team

January 07, 2019

Researchers from Singapore's Duke-NUS Medical School, in collaboration with scientists in China, have identified and characterised a new genus of filovirus from a Rousettus bat in China. Their findings were published in the journal Nature Microbiology. Bat-borne viruses around the world pose a threat to human and animal health. Filoviruses, especially Ebola virus and Marburg virus, are notoriously pathogenic and capable of causing severe and often fatal fever diseases in humans by affecting many organs and damaging blood vessels.

"Studying the genetic diversity and geographic distribution of bat-borne filoviruses is very important for risk assessment and outbreak prevention as this type of infectious disease can affect the general public without warning with devastating consequences," said Professor Wang Lin-Fa, Director of the Emerging Infectious Diseases Signature Research Programme at Duke- NUS Medical School, Singapore, and a senior author of the study.

The researchers discovered the new virus while analysing the diversity of filoviruses in Rousettus bats. They named it the Mengla virus because it was discovered in Megla County, Yunnan Province, China. They detected the virus from a bat sample and conducted sequencing and functional characterization studies.

The results showed that the Menga virus represents a new genus named Dianlovirus within the filovirus group. The Mengla virus is genetically distinct, sharing just 32 percent to 54 percent of its genetic sequence with other known filoviruses. It is found in different geographic locations compared to other filoviruses. This new genus, which could include more than one species, sits in between Ebola virus and Marburg virus on the evolutionary tree.

The researchers tested the Mengla virus in cell lines from various animal species and found that, like other filoviruses, it poses a potential risk of interspecies transmission.

The results confirmed that the Mengla virus is evolutionarily closely related to Ebola virus and Marburg virus and shares several important functional similarities with them. For example, the genome organisation of the Mengla virus is consistent with other filoviruses, coding for seven genes. The Mengla virus also uses the same molecular receptor, a protein called NPC1, as Ebola virus and Marburg virus to gain entry into cells and cause infection.

"The early identification of the filovirus from Rousettus bats by Prof Wang and researchers in China is one of the many strong research collaborations the Emerging Infectious Diseases (EID) Programme at Duke-NUS engages in," noted Professor Patrick Casey, Senior Vice Dean of Research, Duke-NUS Medical School. "With globalisation, it is important to identify and assess the risk of potential infectious disease outbreaks and, from it, develop effective controls strategies and treatments."

At present, the virus has only been identified in Rousettus bats in China. Further tests will be conducted to assess the risk of the virus spreading to other species.
-end-
Reference: Yang XL, Tan CW, Anderson DE, Jiang RD, Li B, Zhang W, Zhu Y, Lim XF, Zhou P, Liu XL, Guan W, Zhang L, Li SY, Zhang YZ, Wang LF and Shi ZL (2018). Characterization of a filovirus (Mengla virus) from Rousettus bats in China. Nature Microbiology. DOI: 10.1038/s41564-018-0328-y

Duke University Medical Center

Related Ebola Virus Articles from Brightsurf:

Targeting the shell of the Ebola virus
As the world grapples with COVID-19, the Ebola virus is again raging.

New universal Ebola vaccine may fight all four virus species that infect humans
Infectious disease scientists report early development of a potential universal vaccine for Ebola viruses that preclinical tests show might neutralize all four species of these deadly viruses infecting people in recent outbreaks, mainly in Africa.

Researchers show how Ebola virus hijacks host lipids
Robert Stahelin studies some of the world's deadliest viruses. Filoviruses, including Ebola virus and Marburg virus, cause viral hemorrhagic fever with high fatality rates.

Recognise and control new variants of the deadly Ebola virus more quickly
Joint press release by the DZIF and Charité. The situation is extraordinary: there have only ever been four declarations of public health emergencies of international concern in the past and now there are two at the same time.

Investigational drugs reduce risk of death from Ebola virus disease
The investigational therapeutics mAb114 and REGN-EB3 offer patients a greater chance of surviving Ebola virus disease (EVD) compared to the investigational treatment ZMapp, according to published results from a clinical trial conducted in the Democratic Republic of the Congo (DRC).

Researchers learn how Ebola virus disables the body's immune defenses
A new study by researchers from The University of Texas Medical Branch at Galveston uncovered new information on why the Ebola virus can exert such catastrophic effects on the infected person.

Mutant live attenuated Ebola virus immunizes non-human primates
Inoculation with an Ebola virus that has mutations in a protein called VP35 does not cause disease and elicits protection in monkeys, researchers show Sept.

Groundbreaking study could lead to fast, simple test for Ebola virus
In a breakthrough that could lead to a simple and inexpensive test for Ebola virus disease, researchers have generated two antibodies to the deadly virus.

RIT professor develops microfluidic device to better detect Ebola virus
A faculty-researcher at Rochester Institute of technology has developed a prototype micro device with bio-sensors that can detect the deadly Ebola virus.

NEJM applying universal standards of care to Ebola virus disease
LSTM's Senior Clinical Lecturer, Dr. Shevin Jacob, is corresponding author on a perspective piece published in the New England Journal of Medicine calling for universal standards of care to be applied in relation to ebola virus disease.

Read More: Ebola Virus News and Ebola Virus Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.